Tumor Necrosis Factor-alpha

1

Review clinical trials related to Tumor Necrosis Factor-alpha. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms

Patients harboring dolichoectactic vertebrobasilar (DVB) aneurysms are at risk of suffering SAH, ischemic stroke, and/or brainstem compression and many patients are not offered invasive treatment due to the futility of existing surgical methods. Consequently, there is demand for development of medical therapy for DVB aneurysms

Participants needed: 8
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: University of California, San FranciscoUpdated: Jun 11, 2026Locations: 1
Eligibility criteria

Vertebral and/or basilar artery dolichoectactic aneurysm not amenable to microsu... [+1]

Use of an anti-TNF or other biologic medication (Including but not limited to ab... [+17]